دواعي استعمال ايموفيج 70مجم/مل اقلام للحقن تحت الجلد 1 مل

Aimovig (erenumab) 70 mg/ml subcutaneous pre-filled pen, 1 pen.

• Preventive treatment of migraine.الفئة: AdultsDailyMed (US National Library of Medicine)

• Most common: injection site reactions and constipation.نشرة دولية لنفس المنتج · DailyMed (US National Library of Medicine)

• Serious hypersensitivity to erenumab or any excipient (anaphylaxis and angioedema reported).نشرة دولية لنفس المنتج · DailyMed (US National Library of Medicine)

• Hypersensitivity reactions (rash, angioedema, anaphylaxis), possibly more than one week after dosing.نشرة دولية لنفس المنتج · DailyMed (US National Library of Medicine)
• Constipation with serious complications, sometimes requiring hospitalisation or surgery.نشرة دولية لنفس المنتج · DailyMed (US National Library of Medicine)
• New or worsening hypertension, most often within 7 days of a dose.نشرة دولية لنفس المنتج · DailyMed (US National Library of Medicine)
• Raynaud's phenomenon (new or worsening); discontinue if suspected.نشرة دولية لنفس المنتج · DailyMed (US National Library of Medicine)

• No adequate human data; no adverse effects on offspring in monkeys; pregnancy exposure registry exists.نشرة دولية لنفس المنتج · DailyMed (US National Library of Medicine)
• No data on presence in human milk; weigh benefits of breastfeeding against maternal need.نشرة دولية لنفس المنتج · DailyMed (US National Library of Medicine)